NEW YORK (GenomeWeb) – Interpace Diagnostics today reported an 8 percent year over year increase in revenues for the second quarter.

For the three months ended June 30, the molecular diagnostics and pathology services firm posted $3.9 million in revenues, up from $3.6 million in the year-ago period.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.